Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines

News Daily News

Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines

December 28, 2021

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

TCTMD’s Top 10 Most Popular Stories for November 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

November 30, 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

November 05, 2021

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

News Conference News TCT 2021

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Michael O'Riordan

November 05, 2021

Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst

News Daily News

Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst

October 28, 2021

Left Main Guideline Review Looms as EACTS Surgeons Urge CABG First

News Conference News EACTS 2021

Left Main Guideline Review Looms as EACTS Surgeons Urge CABG First

Michael O'Riordan

October 19, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

News Conference News VIVA 2021

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

October 12, 2021

Long-term Anticoagulation After Unprovoked VTE: New Insights

News Daily News

Long-term Anticoagulation After Unprovoked VTE: New Insights

September 13, 2021

Could an App Replace Statin Prescribing by Doctors?

News Daily News

Could an App Replace Statin Prescribing by Doctors?

Michael O'Riordan

September 08, 2021

His-bundle Pacing, TAVI Advice Debut in ESC’s Update to Pacing, CRT Guidelines

News Conference News ESC 2021

His-bundle Pacing, TAVI Advice Debut in ESC’s Update to Pacing, CRT Guidelines

September 01, 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care

News Conference News ESC 2021

2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care

August 31, 2021

ACST-2: Carotid Stenting, Surgery Provide Similar Outcomes in Asymptomatic Patients

News Conference News ESC 2021

ACST-2: Carotid Stenting, Surgery Provide Similar Outcomes in Asymptomatic Patients

August 29, 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

August 28, 2021

Endpoint Reporting in Medical Journals Needs to Be Revamped: Review

News Daily News

Endpoint Reporting in Medical Journals Needs to Be Revamped: Review

Michael O'Riordan

August 17, 2021

COVID-19: TCTMD’s Daily Dispatch for August Week 2

News Daily News

COVID-19: TCTMD’s Daily Dispatch for August Week 2

August 08, 2021

COVID-19: TCTMD’s Daily Dispatch for July Week 4

News Daily News

COVID-19: TCTMD’s Daily Dispatch for July Week 4

July 26, 2021

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

News Daily News

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

Yael L. Maxwell

July 15, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.